Work

Results of AFU-GETUG-20: A randomised phase 3 trial of adjuvant androgen deprivation therapy with leuprorelin acetate after radical prostatectomy in patients with high-risk localized prostate cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.386

Authors: Francois Rozet, Alain Ruffion, Michel Soulie, Gregoire Robert, Jochen Walz, Alexandre de la Taille, Christian Pfister, Romain Mathieu, Aurelien Descazeaud, Igor Latorzeff, Laurent Brureau, Marc Colombel, Morgan Roupret, Lise Roca, Pablo Lemercier, Karim Fizazi, Stephane Culine

Institutions: Institute Mutualiste Montsouris, Hôpital Lyon Sud, Hôpital Rangueil, Centre Hospitalier Universitaire de Bordeaux, Institut Paoli-Calmettes, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Centre Hospitalier Universitaire de Rennes, Université de Rennes, Centre Hospitalier Universitaire de Limoges, Centre Hospitalier Universitaire Pointe-à-Pitre, Hôpital Edouard Herriot, Pitié-Salpêtrière Hospital, Institut de Recherche en Cancérologie de Montpellier, Université Paris-Saclay, Institut Gustave Roussy, Hôpital Saint-Louis

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W6884732353

Cites:

Cited by:

Related to: